Financing ·
Basel Medical raises $7.98M in registered direct offering of 6M units at $1.33
BMGLBasel Medical Group Ltd
Basel Medical Group Ltd closed a registered direct offering on October 9, 2026, issuing and selling 6,000,000 units at a public price of US$1.33 per unit. The transaction generated gross proceeds of US$7.98 million and estimated net proceeds of approximately US$7.28 million after deducting commissions and offering expenses. Each unit consists of one ordinary share or pre-funded warrant and one common warrant exercisable at 110% of the offering price, with a five-year term and a zero cash exercise option available to holders. Proceeds are intended for general working capital, mergers and acquisitions, and other corporate purposes. Basel Medical Group Ltd operates as a Singapore-based provider of orthopedic, trauma, sports medicine, and neurosurgical services.